[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100564883":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":32,"responsibleParty":47,"collaborators":30,"id":49,"slug":30,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":30,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":30,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":30,"overallStatus":35,"whyStopped":30,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Fudan University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Segmentectomy","EXPERIMENTAL","Segmentectomy is performed for solid-dominant invasive lung cancer with size of 2-3cm.",[13],"Procedure: Segmentectomy",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","The lungs are divided into multiple lobes. A segmentectomy involves the removal of part of one of the lobes of the lung to entirely remove a cancerous tumor. segmentectomy can preserve more normal functional lung tissues.",[9],[20],"Segment resection",[22],{"name":23,"affiliation":5,"role":24},"Haiquan Chen, M.D.","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Fangqiu Fu, M.D.","CONTACT","+86-13122677592",null,"fufangqiu12@163.com",[33],{"facility":34,"status":35,"city":36,"state":37,"zip":30,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Fudan University Shanghai Cancer Center","RECRUITING","Shanghai","Shanghai Municipality","China",{"type":40,"coordinates":41},"Point",[42,43],121.45806,31.22222,{"lat":43,"lon":42},[46],{"name":27,"role":28,"phone":30,"phoneExt":30,"email":30},{"type":24,"investigatorFullName":48,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Haiquan Chen","100564883",false,"NCT06634966","Segmentectomy for Solid-dominant Lung Cancer","Segmentectomy for Solid-dominant GGO-featured Invasive Lung Cancer With Size of 2-3cm: a Single-arm, Multi-center, Phase III Trial","Inclusion Criteria:\n\n* Patients who sign the informed consent form and are willing to complete the study according to the plan;\n* Aged from 18 to 80 years old;\n* ECOG equals 0 or 1;\n* Not receiving lung cancer surgery before;\n* Confirmed to be invasive lung adenocarcinoma intraoperatively or postoperatively;\n* Ground glass-dominant lung nodules\n* Consolidation-to-tumor ratio (CTR) ranges from 0.5 to 1, and tumor size ranges from 2 to 3cm;\n* cN0 without distant metastasis;\n* Tumors could be completely resected assed by surgeons;\n* Not receiving chemotherapy or radiotherapy before.\n\nExclusion Criteria:\n\n* CTR is not 0.5-1, or size is not 2-3cm;\n* Tumors could not be completely resected assed by surgeons;\n* Not lung adenocarcinoma diagnosed cytologically or pathologically;\n* Receiving lung cancer surgery before;\n* Receiving radiotherapy or chemotherapy.","ALL","18 Years","80 Years",{"count":59,"type":60},277,"ESTIMATED","INTERVENTIONAL",[63],"PHASE3","This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1025. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are:\n\n* The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm;\n* The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.",[9,66],"Lung Adenocarcinoma","2024-10-09",{"date":69,"type":70},"2024-10-10","ACTUAL",{"date":72,"type":70},"2024-07-01",{"date":74,"type":60},"2027-06-30",{"name":5,"class":6},1]